#294 Collaboration, coordination and clinical trials with founder and CEO Zina Sarif
The Healthtech Podcast
00:00
Yendu: The Future of Innovation
Zina: I think it's an incredible idea. And if we can go some way to reducing that billion to 300 million, reducing the 12 years to seven years, red halving the innovation cycle, all these things that you've mentioned. Then let's hope it gives those R&D departments the license to then not only back the drugs with the highest probability of approval, but back the job,. Zina: If it costs only 300 million, now you have VCs back in biotech companies and it's a USB. So you can actually when you're on clinical trial. Yeah. Well, Zina, it's been a pleasure. Thank you so much for joining us.
Transcript
Play full episode
